Skip Navigation

Biostatistics Research Branch (BRB)

Skip Content Marketing
  • Share this:
  • submit to facebook
  • Tweet it
  • submit to reddit
  • submit to StumbleUpon
  • submit to Google +

Mark VanRaden Publications

Engler RJM, Nelson MR, Klote MM, VanRaden MJ, Huang C-Y, Cox NJ, Klimov A, Keitel WA, Nichol KL, Carr WW. Half Dose Trivalent Inactivated Influenza Vaccine (TIV) 2004-05 Compared to Full Dose: Age, Dose and Gender Effects on Immune Responses. Archives of Internal Medicine. 168 (22): 2405-2414, December 2008.

Jewett MW, Lawrence K, Bestor AC, Tilly K, Grimm D, Shaw P, VanRaden M, Gherardini F, Rosa PA. The critical role of the linear plasmid lp36 in the infectious cycle of Borrelia burgdorferi. Molecular Microbiology. 64 (5): 1358-1374, 2007.

Chen-Mok M, VanRaden MJ, Higgs ES, Dominik R.Experiences and challenges in data monitoring for clinical trials within an international tropical disease research network. Clinical Trials: Journal of the Society for Clinical Trials. 3 (5): 469-477, Oct 2006.

Tilly K, Krum JG, Bestor A, Jewett MW, Grimm D, Bueschel D, Byram R, Dorward D, VanRaden MJ, Stewart P, Rosa P. Borrelia burgdorferi OspC protein required exclusively in a crucial early stage of mammalian infection. Infection And Immunity. 74 (6): 3554-3564, Jun 2006.

Simonsen L, Morens DM, Elixhauser A, Gerber M, Van Raden M, Blackwelder WC. Effect of rotavirus vaccination programme on trends in admission of infants to hospital for intussusception. The Lancet. 358 (9289): 1224-1229, Oct 13 2001.

Alter HJ, ConryCantilena C, Melpolder J, Tan D, VanRaden M, Herion D, Lau D, Hoofnagle JH. Hepatitis C in asymptomatic blood donors. Hepatology. 26 (3): S29-S33, Dec 1997.

Blackwelder WC, VanRaden MJ, Deloria MA. Estimation of pertussis vaccine efficacy in the presence of covariates in three randomized trials. Developments In Biological Standardization. 89: 161-166, 1997.

Conry-Cantilena C, VanRaden M, Gibble J, Melpolder J, Shakil AO, Viladomiu L, Cheung L, DiBisceglie A, Hoofnagle J, Shih JW, Kaslow R, Ness P, Alter HJ. Routes of infection, viremia, and liver disease in blood donors found to have hepatitis C virus infection. New England Journal of Medicine. 334 (26): 1691-1696, Jun 27 1996.

Palenicek JP, Graham NMH, He YD, Hoover DA, Oishi JS, Kingsley L, Saah AJ, Armenian H, Farzadegan H, Kass N, Margolick J, McArthur J, Palenicek J, Taylor E, Phair JP, Chmiel JS, Cohen B, Ogorman M, Murphy R, Variakojis D, Wesch J, Wolinsky S, Detels R, Visscher B, Chen I, Dudley J, Fahey J, Giorgi J, Lee M, Martinezmaza O, Miller E, Morgenstern H, Nishanian P, Taylor J, Zack J, Rinaldo C, Becker J, Gupta P, Ho M, Zucconi LS, Munoz A, Beaty T, Epstein L, Galai N, Hoover D, Jacobson LP, Kuo V, Mienert C, Nelson K, Piantadosi S, Su S, Schrager L, Vermund S, Kaslow R, VanRaden M, Obrams I, Seminara D. Weight-loss prior to clinical AIDS as a predictor of survival. Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology. 10 (3): 366-373, Nov 1 1995.

Giorgi JV, Ho HN, Hirji K, Chou CC, Hultin LE, Orourke S, Park L, Margolick JB, Ferbas J, Phair JP, Saah AJ, Armenian H, Farzadegan H, Graham N, McArthur J, Palenicek J, Munoz A, Hoover D, Galai N, Jacobson LP, Piantadosi S, Su S, Bauer K, Chmiel JS, Cohen B, Variakojis D, Wesch J, Wolinsky SM, Detels R, Visscher BR, Chen I, Dudley J, Fahey JL, Martinezmaza O, Nishanian P, Taylor J, Zack J, Rinaldo CR, Becker JT, Gupta P, Ho M, Kingsley L, Schrager L, Kaslow RA, VanRaden MJ, Seminara D. CD8+ lymphocyte-activation at Human-Immunodeficiency-Virus type-1 seroconversion - development of HLA-DR+ CD38- CD8+ cells is associated with subsequent stable CD4+ cell levels. Journal of Infectious Diseases. 170 (4): 775-781, Oct 1994.

Zucconi, SL; Jacobson, LP; Schrager, LK; Kass, NE; Lave, Jr; Carson, CA; Morgenstern, H; Arno, PS; Graham, NMH; Saah, AJ; Palenicek, J; Armenian, H; Farzadegan, H; Margolick, J; Macarthur, J; Phair, JP; Chmiel, J; Cohen, B; Ogorman, M; Variakojis, D; Wesch, J; Wolinsky, S; Detels, R; Visscher, B; Chen, I; Dudley, J; Fahey, J; Giorgi, J; Lee, M; Martinezmaza, O; Miller, E; Nishanian, P; Taylor, J; Zack, J; Rinaldo, C; Kingsley, L; Becker, J; Gupta, P; Ho, M; Munoz, A; Beaty, T; Epstein, L; Galai, N; Hoover, D; Meinert, C; Nelson, K; Piantadosi, S; Su, S; Schrager, L; Vermund, S; Kaslow, R; VanRaden, M; Seminara, D. Impact of immunosuppression on health-care use by men in the Multicenter AIDS Cohort Study (MACS). Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology. 7 (6): 607-616, Jun 1994.

Lyketsos, CG; Hoover, Dr; Guccione, M; Senterfitt, W; Dew, MA; Wesch, J; VanRaden, MJ; Treisman, GJ; Morgenstern, H.  Depressive symptoms as predictors of medical outcomes in HIV-infection. Journal of The American Medical Association. 270 (21): 2563-2567, Dec 1 1993.

Groothuis, JR; Simoes, EAF; Levin, MJ; Hall, CB; Long, CE; Rodriguez, WJ; Arrobio, J; Meissner, HC; Fulton, DR; Welliver, RC; Tristram, DA; Siber, GR; Prince, GA; VanRaden, M; Hemming, VG. Prophylactic administration of respiratory syncytial virus immune globulin to high-risk infants and young-children. New England Journal of Medicine. 329 (21): 1524-1530, Nov 18 1993.

McArthur,JC; Hoover, DR’ Bacellar, H; Miller, EN; Cohen, BA; Becker, JT; Graham, NMH; Mcarthur, JH; Selnes, OA; Jacobson, LP; Visscher, BR; Concha, M; Saah, A; Palenicek, J; Armenian, H; Farzadegan, H; Margolick, J; Phair, JP; Chmiell, JS; Bauer, K; Variakojis, D; Wesch, J; Wolinsky, SM; Detels, R; Chen, I; Dudley, J; Fahey, JL; Giorgi, JV; Martinezmaza, O; Nishanian, P; Taylor, J; Zack, J; Rinaldo, CR; Kingsley, L; Gupta, P; Ho, M; Munoz, A; Beaty, T; Galai, N; Meinert, C; Nelson, K; Piantadosi, S; Seminara, D; Su, S; Schrager, L; Vermund, SH; Kaslow, RA; VanRaden, MJ; Obrams, I. Dementia in AIDS patients - incidence and risk-factors. Neurology. 43 (11): 2245-2252, Nov 1993.

Zhou, SYJ; Kingsley, LA; Taylor, JMG; Chmiel, JS; He, DY; Hoover, DR; Saah, A; Farzadegan, H; Margolick, J; Mcarthur, J; Phair, JP; Chmiel, JS; Cohen, B; Wesch, J; Wolinsky, S; Rinaldo, CR; Gupta, P; Ho, M; Kingsley, LA; Anderson, R; Detels, R; Visscher, BR; Dudley, J; Fahey, JL; Giorgi, JV; Imagawa, D; Taylor, J; Munoz, A; Bacellar, H; Carey, V; Hoover, D; Jacobson, LP; Su, S; He, DY; Vermund, S; Schrager, L; Kaslow, RA; VanRaden, MJ. A method to test for a recent increase in HIV-1 seroconversion incidence - results from the Multicenter AIDS Cohort Study (MACS). Statistics In Medicine. 12 (2): 153-164, Jan 30 1993.

Hoover, D; Muñoz, A; Carey, V; Taylor, JMG; VanRaden, M; Chmiel, JS; Kingsley, L’ and the Multicenter AIDS Cohort Study. Using events from dropouts in nonparametric survival function estimation with application to incubation of AIDS. Journal of the American Statistical Association 88: 421: 37‑43, 1993.

Lyketsos, C; Hoover, D; Guccione, M; Senterfitt, W; Dew, M; Mesch, J; VanRaden, M; Treisman, G; Morgenstern, H; for the Multicenter AIDS Cohort Study (MACS). Depressive symptoms as predictors of medical outcomes in HIV Infection. Journal of the American Medical Association. 270:2563-7, 1993.

Muñoz, A; Carey, V; Taylor, JMG; Chmiel, JS; Kingsley, L; VanRaden, M; Hoover, DR. Estimation of time since exposure for a prevalent cohort. Statistics in Medicine. 11: 939-952, May 1992.

Kingsley, LA; Zhou, SYJ; Bacellar, H; Rinaldo, CR; Chmiel, J; Detels, R; Saah, A; VanRaden, M; Ho, M; Munoz, A.  Temporal trends in Human-Immunodeficiency-Virus type-1 seroconversion 1984-1989 - a report from the Multicenter AIDS Cohort Study (MACS). American Journal of Epidemiology. 34 (4): 331-339, Aug 15 1991.

Solomon, R; VanRaden, M; Kaslow, R; Lyter, D; Visscher, B; Farzadegan, H; Phair, J for the Multicenter AIDS Cohort Study (MACS). Association of hepatitis B surface-antigen and core antibody with acquisition and manifestations of human- immunodeficiency-virus type 1 (HIV-1) infection. American Journal of Public Health. 80:1475-1478, Dec 1990.

Alter HJ, Epstein JS, Swenson SG, VanRaden MJ, Ward JW, Kaslow RA, Menitove JE, Klein HG, Sandler SG, Sayers MH, Hewlett IK, Chernoff AI. Prevalence of human-immunodeficiency-virus type-1 p24 antigen in United-States blood-donors - an assessment of the efficacy of testing in donor screening. New England Journal of Medicine. 323 (19): 1312-1317, Nov 8 1990.

Ostrow, DG; VanRaden, M; Fox, R; Kingsley, L; Dudley, J; Kaslow, R, and the Multicenter AIDS Cohort Study (MACS). Recreational drug use and sexual behavior change in a cohort of homosexual men. AIDS. 4 (8):759-765, Aug 1990.

Kaslow, RA; Kingsley, L; Su, S; Duquesnoy, R; Marrari, M; Detels, R; Rinaldo, C; Saah, A; Phair, J; VanRaden, M; Friedman, H. A1, Cw7, B8, DR3 HLA antigen combination associated with rapid decline of T-helper lymphocytes in HIV-1 infection. The Lancet. 335: 8695: 927-930, April 21, 1990.

Ostrow, DG; Monjan, A; Joseph, J; VanRaden, MJ; Fox, R; Kingsley, L; Dudley, J; Phair, J; and the Multicenter AIDS Cohort Study (MACS). HIV-Related Symptoms and Psychological Functioning in a Cohort of Homosexual Men. American Journal of Psychiatry. 146:6: 737-742, June 1989.

Solomon, RE; Kaslow, RA; Phair, JP; Lyter, D; Visscher, B; Lyman, D; VanRaden, MA; and Gerin, J. Immunodeficiency Virus and Hepatitis Delta Virus in Homosexual Men: A study of Four Cohorts. Annals of Internal Medicine. 108: 51-54, 1988.

Kingsley, LA; Kaslow, RA; Rinaldo, CR; Detre, K; Odaka, N; VanRaden, MJ; Detels, R; Polk, BF; Chmiel, J; Kelsey, SF; Ostrow, D; Visscher, B. Risk Factors for Seroconversion to Human Immunodeficiency Virus Among Male Homosexuals. The Lancet. (8529): 345-349, Feb 14 1987.

Chmiel, JS; Detels, R; Kaslow, RA; VanRaden, MJ; Kingsley, LA; Brookmeyer, R; and the Multicenter AIDS Cohort Study Group. Factors Associated with Prevalent Human Immunodeficiency Virus (HIV) Infection in the Multicenter AIDS Cohort Study. American Journal of Epidemiology. 126;4: 568-577, 1987.

Ostrow, DG; Joseph, J; Monjan, A; Kessler, R; Emmons, C; Phair, J; Fox, R; Kingsley, L; Dudley, J; Chmiel, JS; Vanraden, MJ. Psychosocial Aspects of AIDS Risk. Psychopharmacology Bulletin. 22 (3): 678-683, 1986.

Bentivoglio, LG; VanRaden, MJ; Kelsey, SF; and Detre, KM. Percutaneous transluminal coronary angioplasty (PTCA) in patients with relative contraindications. Results of the National Heart, Lung and Blood Institute Registry on PTCA. American Journal of Cardiology. 53 (12): C82-C88, 1984.

Detre, KM; Myler, RK; Kelsey, SF; VanRaden, M; and To, T. Baseline characteristics of patients in the NHLBI percutaneous transluminal coronary angioplasty registry. American Journal of Cardiology. 53 (12): C7-C11, 1984.

Dorros G, Cowley MJ, Janke L, Kelsey SF, Mullin SM, Vanraden M. The in-hospital mortality rate in the National Heart, Lung and Blood Institute percutaneous transluminal coronary angioplasty registry. American Journal of Cardiology. 53 (12): C131-C135, 1984.

Faxon, DP; Detre, K; McCabe, CH; Fisher, L; Holmes, D; Cowley, M; Bourassa, M; VanRaden, M; and Ryan, T. The role of percutaneous transluminal coronary angioplasty in the treatment of patients with unstable angina: a report from the NHLBI PTCA and CASS registries. American Journal of Cardiology. 53 (12): C17-C21, 1984.

Holmes, DR; VanRaden, MJ; Reeder, GS; Vlietstra, RE; Jang, GC; Kent, KM; Vetrovec, GW; Cowley, MJ; Dorros, G; Kelsey, SF; Detre, KM; and Mock, MB. Return to work after coronary angioplasty: a report from the NHLBI PTCA registry. American Journal of Cardiology. 53 (12): C48-C51, 1984.

Rosing, DR; VanRaden, MJ; Mincemoyer, RM; Bonow, RO; Bourassa, MG; David, PR; Ewels, CJ; Kent, KM; and Detre, KM. Exercise, electrocardiographic, and functional responses after percutaneous transluminal coronary angioplasty (PTCA). American Journal of Cardiology. 53 (12): C36-C41, 1984.

Holmes, DR; Vlietstra, RE; Smith, HC; Vetrovec, GW; Kent, KM; Cowley, MJ; Faxon, DP; Gruentzig, AR; Kelsey, SF; Detre, KM; VanRaden, MJ; and Mock, MB. Restenosis after percutaneous transluminal coronary angioplasty: a report from the NHLBI registry. American Journal of Cardiology. 53 (12): C77-C81, 1984.

Cowley, MJ; Dorros, G; Kelsey, SF; Vanraden, M; Detre, KM. Acute coronary events associated with percutaneous trans-luminal coronary angioplasty. American Journal of Cardiology. 53 (12): C12-C16, 1984.

Cowley, MJ; Dorros, G; Kelsey, SF; Vanraden, M; Detre, KM. Emergency coronary-bypass surgery after coronary angioplasty - the National Heart Lung and Blood Institutes percutaneous trans-luminal coronary angioplasty registry experience. American Journal of Cardiology. 53 (12): C22-C26, 1984.

Kent, KM; Bentivoglio, LG; Block, PC; Bourassa, MG; Cowley, MJ; Dorros, G; Detre, KM; Gosselin, AJ; Gruentzig, AR; Kelsey, SF; Mock, MB; Mullin, SM; Passamani, ER; Myler, RK; Simpson, J; Stertzer, SH; VanRaden, MJ; Williams, DO. Long-term efficacy of percutaneous trans-luminal coronary angioplasty (PTCA) - report from the National Heart Lung and Blood Institute PTCA registry. American Journal of Cardiology. 53 (12): C27-C31, 1984.

Mock, MB; Holmes, DR; Vlietstra, RE; Gersh, BJ; Detre, KM; Kelsey, SF; Orszulak, TA; Schaff, HV; Piehler, JM; Vanraden, MJ; Passamani, ER; Kent, KM; Gruentzig, AR. Percutaneous trans-luminal coronary angioplasty (PTCA) in the elderly patient - experience in the National Heart Lung and Blood Institute PTCA registry. American Journal of Cardiology. 53 (12): C89-C91, 1984.

back to top

Last Updated June 21, 2009